{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:39:08Z","timestamp":1791344348996,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jbspin.2012.08.013","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T03:18:03Z","timestamp":1351567083000},"page":"141-145","source":"Crossref","is-referenced-by-count":56,"title":["Mast cells and inflammation"],"prefix":"10.1016","volume":"80","author":[{"given":"Laurent","family":"Frenzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2012.08.013_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90302-U","article-title":"Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0020","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/ibd.21218","article-title":"Gastrointestinal involvement and manifestations in systemic mastocytosis","volume":"16","author":"Sokol","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clineuro.2011.05.002","article-title":"Neurologic symptoms and diagnosis in adults with mast cell disease","volume":"113","author":"Smith","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0030","doi-asserted-by":"crossref","first-page":"e26375","DOI":"10.1371\/journal.pone.0026375","article-title":"Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy","volume":"6","author":"Moura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1398-9995.2008.01806.x","article-title":"Mastocytosis is not related to allergic diseases","volume":"63","author":"Dewachter","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0040","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.0906-6705.2003.0109a.x","article-title":"What is the physiological function of mast cells?","volume":"12","author":"Maurer","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1196\/annals.1443.023","article-title":"Mast cells: multifaceted immune cells with diverse roles in health and disease","volume":"1143","author":"Rao","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaci.2004.04.045","article-title":"Mast cells in innate immunity","volume":"114","author":"Marshall","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0065","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2009-05-220004","article-title":"Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation","volume":"114","author":"Piconese","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0075","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0080","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"A cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0085","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Mast cells express IL17A in rheumatoid arthritis synovium","volume":"184","author":"Hueber","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.182.1.647","article-title":"Mast cells contribute to autoimmune inflammatory arthritis via their tryptase\/heparin complexes","volume":"182","author":"Shin","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0095","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.22936","article-title":"Protease-activated receptor 2 mediates the pro inflammatory effect of synovial mast cells","volume":"56","author":"Palmer","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/ard.2010.138032","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role of mast cells and basophils?","volume":"70","author":"Suurmond","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ana.410370112","article-title":"Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients","volume":"37","author":"Rozniecki","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.20072404","article-title":"The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease","volume":"205","author":"Carlson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbadis.2011.02.009","article-title":"New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?","volume":"1822","author":"Walker","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0125","doi-asserted-by":"crossref","first-page":"e7258","DOI":"10.1371\/journal.pone.0007258","article-title":"Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT","volume":"4","author":"Dubreuil","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study","volume":"85","author":"Paul","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0135","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar2740","article-title":"Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study","volume":"11","author":"Tebib","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0140","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1398-9995.2009.02122.x","article-title":"Masitinib, a c-kit\/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics","volume":"64","author":"Humbert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/alzrt75","article-title":"Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial","volume":"3","author":"Piette","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jbspin.2012.08.013_bib0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2377-12-36","article-title":"Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study","volume":"12","author":"Vermersch","year":"2012","journal-title":"BMC Neurol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T19:01:34Z","timestamp":1542654094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X12002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1297319X12002035"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2012.08.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}